|
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries |
Knight GM, Griffiths UK, Sumner T, Laurence YV, Gheorghe A, Vassall A, Glaziou P, White RG |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Knight GM, Griffiths UK, Sumner T, Laurence YV, Gheorghe A, Vassall A, Glaziou P, White RG. Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries. Proceedings of the National Academy of Sciences of the United States of America 2014; 111(43): 15520-15525 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Calibration; Cost-Benefit Analysis; Developing Countries /economics; Humans; Income; Infant; Models, Economic; Tuberculosis /economics /immunology /mortality /prevention & Tuberculosis Vaccines /economics; Uncertainty; control AccessionNumber 22014038573 Date bibliographic record published 11/12/2014 |
|
|
|